POULTRY VACCINE MARKET ANALYSIS

Poultry Vaccine MarketSize and Trends

The global poultry vaccine market was valued at US$ 1,766.8 Mn in 2022 and is forecast to reach a value of US$ 3,240.2 Mn by 2030 at a CAGR of 7.9% between 2023 and 2030.

Global Poultry Vaccine Market Trends:

Rise in focus on vaccine development is a recent trend

Over the years, the poultry vaccines market has evolved rapidly, in terms of product development. Players in the market as well as researchers and new vaccine companies are focusing on developing and launching safe and effective vaccines in the market. Researchers at the Pirbright Institute, have developed a new method of the genetically-modified vaccines to protect against infectious bursal disease (IBD), avian influenza, and Newcastle disease. This trend is expected to continue over the forecast period, driving the growth of the market.

Increase in use of biotechnologies is another trend

The poultry industry has leveraged biotechnologies to improve the safety and convenience of avian vaccination. The vector technology scheme/plan is expected to play an important role in delivering the active component of the vaccine to the animal. For instance, Merial's VAXXITEK HVT + IBD is one of the leading vector vaccines, available in about 75 countries, worldwide. The development of new technologies will stimulate development of improved products to protect against dangerous strains of the virus. This trend is also expected to continue during the forecast period.

Market- Trends

Global Poultry Vaccine Market Segmentation:

The global poultry vaccine market report is segmented into Disease, Technology, and Geography.

Based on Technology, the poultry vaccine market is segmented into Live Attenuated Vaccines (LAV), Recombinant Vaccines, Inactivated Vaccines, and Other Technologies. Out of which, Live Attenuated Vaccines (LAV) Segment is expected to dominate the market over the forecast period and this is attributed to the increase in usage of live attenuated vaccines. Live attenuated vaccines (LAV) are being widely applied to vaccination programs.

Recombinant Vaccines Segment is also expected to witness significant growth in the near future and this is owing to the increase in demand for recombinant vaccines. Recombinant viruses were employed as bivalent, live-virus vaccines to immunize chickens against avian influenza.